How New Federal Laws and Recent Court Rulings Are Transforming Valuation of Assets & Product Lifecycle Management - BioNJ Legal, Compliance & Regulatory Forum

Apr 26 2023

Linda Pissott Reig, shareholder in the firm's FDA practice, moderated the hot topics roundtable during BioNJ's Legal, Compliance & Regulatory Forum on April 26. Mythili Markowski, counsel in the firm's Life Sciences industry group, also served as a panelist for the discussion. The panelists discussed new federal laws and recent court rules that are having a direct impact on pricing strategies, product value stories and how product portfolios are managed and expanded. The program included scenarios and interactive discussion that allowed attendees to better understand the recent major law updates and how they impact the life sciences industry.